| scholarly article | Q13442814 |
| P50 | author | Alessio Petrelli | Q40700653 |
| Mariella Trovati | Q43623001 | ||
| Franco Cavalot | Q59669549 | ||
| P2093 | author name string | Conti M | |
| Costa G | |||
| Anfossi G | |||
| Bonomo K | |||
| Fiora E | |||
| Traversa M | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| glucose | Q37525 | ||
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 813-819 | |
| P577 | publication date | 2005-12-13 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study | |
| P478 | volume | 91 |
| Q42865106 | 3rd Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 7–8, 2010, London, UK |
| Q33588613 | A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges |
| Q27301757 | A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice |
| Q58447173 | A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients |
| Q38802810 | A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus. |
| Q37694033 | A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress |
| Q34018145 | A single-center, open, comparative study of the effect of using self-monitoring of blood glucose to guide therapy on preclinical atherosclerotic markers in type 2 diabetic subjects |
| Q38183127 | A systematic review and meta-analysis of the efficacy of lixisenatide in the treatment of patients with type 2 diabetes |
| Q46639644 | Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: a randomised cross-over clinical trial. |
| Q52536332 | Adding prandial GLP-1 receptor agonists to basal insulin: a promising option for type 2 diabetes therapy. |
| Q34793839 | Additive effects of postchallenge hyperglycemia and low-density lipoprotein particles on the risk of arterial stiffness in healthy adults. |
| Q38003114 | Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation |
| Q37403957 | Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3) |
| Q63976693 | An Oral Glucose Load Decreases Postprandial Extracellular Vesicles in Obese Adults with and without Prediabetes |
| Q49824036 | Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic. |
| Q33698706 | Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract |
| Q37404577 | Arguments for and against the role of glucose variability in the development of diabetes complications |
| Q42745518 | Assessment of glycemic control: new insights into the evaluation of the diabetic patient |
| Q93116072 | Association between breakfast skipping and postprandial hyperglycaemia after lunch in healthy young individuals |
| Q36392849 | Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality |
| Q57074595 | Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease |
| Q42700690 | Association of lower body mass index with increased glycemic variability in patients with newly diagnosed type 2 diabetes: a cross-sectional study in China. |
| Q38734928 | Atherogenicity of postprandial hyperglycemia and lipotoxicity. |
| Q37737452 | Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study |
| Q26992979 | Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making |
| Q38893233 | Baseline level of 30-min plasma glucose is an independent predictor of incident diabetes among Asian Indians: analysis of two diabetes prevention programmes |
| Q36818859 | BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin |
| Q63976818 | Behavioral Strategies to Lower Postprandial Glucose in Those with Type 2 Diabetes May Also Lower Risk of Coronary Heart Disease |
| Q37008622 | Blunting post-meal glucose surges in people with diabetes |
| Q91926297 | Breakfast consumption modulates postprandial glycaemic, insulinaemic and NEFA response in pre-diabetic Asian males |
| Q34030881 | Breaking up prolonged sitting reduces postprandial glucose and insulin responses |
| Q38764063 | Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: A randomized crossover trial |
| Q42123265 | Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. |
| Q36828268 | Carotid Intima Media Thickness in Nondiabetic Hypertensive Nigerians: Role of Fasting and Postprandial Blood Glucose |
| Q53614305 | Coffee bean polyphenols ameliorate postprandial endothelial dysfunction in healthy male adults. |
| Q36835841 | Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease |
| Q33603569 | Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30. |
| Q33809279 | Comparison of multiple and novel measures of dietary glycemic carbohydrate with insulin resistant status in older women |
| Q40476976 | Concentric and eccentric exercise, glycemic responses to a postexercise meal, and inflammation in women with high versus low waist circumference. |
| Q37890790 | Control of postprandial glucose levels with insulin in type 2 diabetes |
| Q42707626 | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
| Q97523185 | Daily mycoprotein consumption for one week does not affect insulin sensitivity or glycaemic control but modulates the plasma lipidome in healthy adults: a randomised controlled trial |
| Q38634051 | Dapagliflozin combination therapy in type 2 diabetes mellitus |
| Q57939070 | Death by Carbs: Added Sugars and Refined Carbohydrates Cause Diabetes and Cardiovascular Disease in Asian Indians |
| Q58616295 | Deep Multi-OMICs and Multi-Tissue Characterization in a Pre- and Postprandial State in Human Volunteers: The GEMM Family Study Research Design |
| Q34607382 | Diabetes and biomarkers |
| Q34997385 | Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop |
| Q26749281 | Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes |
| Q48151781 | Do all patients with type 2 diabetes need breakfast? |
| Q30666747 | Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes |
| Q37772461 | Does postprandial blood glucose matter and why? |
| Q44556012 | Effect of 2 liquid nutritional supplements for diabetes patients on postprandial glucose, insulin secretion, and insulin sensitivity in healthy individuals |
| Q34438901 | Effect of a low dose whey/guar preload on glycemic control in people with type 2 diabetes--a randomised controlled trial |
| Q35117192 | Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study |
| Q51166057 | Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment. |
| Q37278096 | Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes |
| Q37605460 | Effective use of paired testing in type 2 diabetes: practical applications in clinical practice |
| Q34180942 | Effects of a structured self-monitoring of blood glucose method on patient self-management behavior and metabolic outcomes in type 2 diabetes mellitus |
| Q30408824 | Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults |
| Q36825694 | Effects of glucose load and nateglinide intervention on endothelial function and oxidative stress |
| Q51840119 | Effects of high-intensity interval exercise versus continuous moderate-intensity exercise on postprandial glycemic control assessed by continuous glucose monitoring in obese adults. |
| Q35363465 | Effects of intravenous glucose and lipids on innate immune cell activation in healthy, obese, and type 2 diabetic subjects |
| Q48140197 | Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes. |
| Q51364256 | Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes. |
| Q46133537 | Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus |
| Q49389012 | Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial |
| Q50961272 | Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. |
| Q35289717 | Exercise prior to a freely requested meal modifies pre and postprandial glucose profile, substrate oxidation and sympathovagal balance |
| Q35898240 | Exercise therapy in type 2 diabetes: is daily exercise required to optimize glycemic control? |
| Q26748720 | Exercising Tactically for Taming Postmeal Glucose Surges |
| Q38055296 | Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR. |
| Q51252378 | Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. |
| Q37169720 | Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women |
| Q37825946 | Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control. |
| Q35085599 | Glucose and triglyceride excursions following a standardized meal in individuals with diabetes: ELSA-Brasil study. |
| Q51469263 | Glucose tolerance is negatively associated with circulating progenitor cell levels. |
| Q90422090 | Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability |
| Q39296810 | Glucose: archetypal biomarker in diabetes diagnosis, clinical management and research |
| Q35845203 | Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes |
| Q34374343 | Glycemic Control and Weight Reduction Without Causing Hypoglycemia: The Case for Continued Safe Aggressive Care of Patients With Type 2 Diabetes Mellitus and Avoidance of Therapeutic Inertia |
| Q26795377 | Glycemic Variability: How Do We Measure It and Why Is It Important? |
| Q37189312 | Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents |
| Q37404282 | Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? |
| Q100508192 | Glycosylated hemoglobin A1c predicts coronary artery disease in non-diabetic patients |
| Q38402571 | Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism. |
| Q33871384 | Heterogeneity of glycometabolism in patients with gestational diabetes mellitus: Retrospective study of 1,683 pregnant women |
| Q38269921 | High-intensity interval training for improving postprandial hyperglycemia. |
| Q41465403 | Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus |
| Q43180127 | How to interpret results of the HEART2D trial? |
| Q92901781 | Impact of Short-Term Continuous and Interval Exercise Training on Endothelial Function and Glucose Metabolism in Prediabetes |
| Q35060211 | Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients |
| Q38016729 | Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. |
| Q47443616 | Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes |
| Q33871377 | Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes |
| Q42745517 | Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors |
| Q36509951 | Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion |
| Q36535920 | Improving the Quality of Outpatient Diabetes Care Using an Information Management System: Results From the Observational VISION Study |
| Q51361959 | Influence of increasing BMI on insulin sensitivity and secretion in normotolerant men and women of a wide age span. |
| Q47720242 | Influence of rice, pea and oat proteins in attenuating glycemic response of sugar-sweetened beverages |
| Q35215364 | Inhibition of the intestinal sodium-coupled glucose transporter 1 (SGLT1) by extracts and polyphenols from apple reduces postprandial blood glucose levels in mice and humans |
| Q34126929 | Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data |
| Q37479419 | Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept |
| Q35165870 | Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement |
| Q37240511 | International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations |
| Q89159597 | Lixisenatide - A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 Diabetes |
| Q36554216 | Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects |
| Q40344735 | Long-term effects of daily postprandial physical activity on blood glucose: a randomized controlled trial |
| Q36119556 | Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone |
| Q28534935 | Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study |
| Q36001089 | Lowering physical activity impairs glycemic control in healthy volunteers |
| Q57095268 | Lupin and soya reduce glycaemia acutely in type 2 diabetes |
| Q64053831 | Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation |
| Q38717505 | Measurement of Hyperglycemia and Impact on Health Outcomes in People With Cancer: Challenges and Opportunities |
| Q40220125 | Metabolic changes in serum metabolome in response to a meal. |
| Q42180113 | Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes |
| Q44055789 | Non-fasting blood glucose and risk of incident coronary heart disease in middle-aged general population: the Circulatory Risk in Communities Study (CIRCS). |
| Q64259279 | Non-traditional risk factors for coronary calcification and its progression in patients with type 2 diabetes: The impact of postprandial glycemia and fetuin-A |
| Q95360575 | Nonfat milk attenuates acute hyperglycemia in individuals with android obesity: A randomized control trial |
| Q42171602 | Noninvasive Continuous Glucose Monitoring Using a Multisensor-Based Glucometer and Time Series Analysis |
| Q53063504 | Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes. |
| Q58420586 | Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects |
| Q37717838 | On the potential of acarbose to reduce cardiovascular disease |
| Q33678580 | One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study |
| Q33488897 | Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses |
| Q47769561 | Optimal prandial timing of bolus insulin in diabetes management: a review. |
| Q34304732 | Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. |
| Q34411561 | Phlorotannins from Alaskan seaweed inhibit carbolytic enzyme activity. |
| Q87663139 | Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome |
| Q42707636 | Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target |
| Q37960779 | Post-prandial glucose and diabetic complications: systematic review of observational studies |
| Q38460480 | Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies |
| Q35225468 | Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study |
| Q94483643 | Postprandial blood glucose response: does the glycaemic index (GI) value matter even in the low GI range? |
| Q48029603 | Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin |
| Q37319194 | Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population. |
| Q36051229 | Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal |
| Q42731432 | Postprandial glucose: marker or risk factor? |
| Q33568890 | Postprandial glycaemic response of foxtail millet dosa in comparison to a rice dosa in patients with type 2 diabetes |
| Q48420945 | Postprandial glycemia and appetite sensations in response to porridge made with rolled and pinhead oats |
| Q43177184 | Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? |
| Q36783700 | Postprandial hyperglycemia and glycemic variability: should we care? |
| Q37464262 | Postprandial hyperglycemia as an etiological factor in vascular failure |
| Q51386318 | Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease. |
| Q34070530 | Postprandial oxidative stress and gastrointestinal hormones: is there a link? |
| Q33556716 | Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes |
| Q26765224 | Potential medicinal benefits of Cosmos caudatus (Ulam Raja): A scoping review |
| Q51541168 | Potentiation of the early-phase insulin response by a prior meal contributes to the second-meal phenomenon in type 2 diabetes. |
| Q33896433 | Pramlintide and the treatment of diabetes: a review of the data since its introduction |
| Q58829102 | Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes |
| Q43048700 | Pre-mixed rapid-acting insulin 50/50 analogue twice daily is useful not only for controlling post-prandial blood glucose, but also for stabilizing the diurnal variation of blood glucose levels: switching from pre-mixed insulin 70/30 or 75/25 to pre- |
| Q34999016 | Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome |
| Q44991769 | Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. |
| Q92324116 | Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin |
| Q84357462 | Progression of type 2 diabetes and insulin initiation |
| Q37501952 | Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention |
| Q36282005 | Relationship between Type 2 Diabetes and Inflammation Diseases: Cohort Study in Chinese Adults |
| Q33794986 | Relationship between modified homeostasis model assessment/correlative serum factors and diabetic retinopathy among type 2 diabetics with insulin therapy in Guangzhou, China |
| Q48818335 | Replacement of glycaemic carbohydrates by inulin-type fructans from chicory (oligofructose, inulin) reduces the postprandial blood glucose and insulin response to foods: report of two double-blind, randomized, controlled trials |
| Q37742818 | Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. |
| Q43483472 | Risk factors for type 2 diabetes among female Pakistani immigrants: the InvaDiab-DEPLAN study on Pakistani immigrant women living in Oslo, Norway |
| Q45806451 | Role of Oral Agents in Improving Cardiovascular Prognosis in Diabetes Mellitus–Reply–I. |
| Q37632301 | Role of melatonin in metabolic regulation |
| Q33610665 | Shifting the disease management paradigm from glucose: what are the pros? |
| Q39140474 | Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review. |
| Q90581308 | Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus |
| Q47236684 | Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein. |
| Q64086648 | Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives |
| Q34541875 | Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. |
| Q30365724 | Structured SMBG in early management of T2DM: Contributions from the St Carlos study. |
| Q33610724 | Target for glycemic control: concentrating on glucose |
| Q48123950 | Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges |
| Q46381353 | Targeting prandial hyperglycemia: how important is it and how best to do this? |
| Q36712197 | The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries |
| Q33598321 | The Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta Cells |
| Q48211404 | The Role of Glycemic Control and Variability in Diabetic Retinopathy |
| Q34024341 | The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study |
| Q36845055 | The effects of dipeptidyl peptidase-4 inhibitors on cardiovascular disease risks in type 2 diabetes mellitus |
| Q37044964 | The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus |
| Q33776092 | The incretin system and cardiometabolic disease |
| Q36718597 | The role of glucose as an independent cardiovascular risk factor |
| Q37321871 | The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. |
| Q55431482 | The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective. |
| Q42475429 | Time-dependent changes in the expression of lymphocyte and monocyte cell adhesion molecules after meals of different composition |
| Q89054963 | Timely exercise for controlling glucose and oxidative stress |
| Q89666056 | Traumatic Stress, Attachment Style, and Health Outcomes in Cardiac Rehabilitation Patients |
| Q35682627 | Treatment with novel galactomannan derivative reduces 2-hour postprandial glucose excursions in individuals with type 2 diabetes treated with oral medications and/or insulin |
| Q57181583 | Twenty Minute Moderate-Intensity Post-Dinner Exercise Reduces the Postprandial Glucose Response in Chinese Patients with Type 2 Diabetes |
| Q58778740 | Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina |
| Q34023548 | Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? |
| Q37104865 | Type 2 diabetes mellitus: prevention of macrovascular complications. |
| Q33813768 | Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk |
| Q36989716 | Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA. |
| Q37161925 | Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents |
| Q36195667 | Usefulness of glycated hemoglobin as diagnostic criteria for metabolic syndrome |
| Q37404411 | Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes |
| Q44461689 | Variability of blood glucose concentration and short-term mortality in critically ill patient |
| Q64063218 | Water-soluble polyphenol-rich clove extract lowers pre- and post-prandial blood glucose levels in healthy and prediabetic volunteers: an open label pilot study |
| Q37606022 | What are the best options for controlling prandial glycemia? |
| Q39038925 | What next after basal insulin? Treatment intensification with lixisenatide in Asian patients with type 2 diabetes mellitus |
| Q58126220 | [Effect of moderate exercise for 30 min at 30 min versus 60 min after dinner on glycemic control in patients with type 2 diabetes: a randomized, crossover, self-controlled study] |
Search more.